Hepatitis and monkeypox: Clinical presentation and co-infection

Elsevier, iLIVER, Volume 1, Issue 2, June 2022, Pages 139-140
Authors: 
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

New zoonotic pox diseases have emerged, posing a global concern in addition to the well-known pox infections [1]. Monkeypox is an uncommon kind of pox that has reappeared due to zoonosis [1]. By 2022, monkeypox had spread throughout Europe and North America, creating a serious public health risk [2]. Monkeypox is an uncommon and little-known type of pox that has reappeared as a result of zoonosis. Human-to-human transfer is being researched at the moment [1]. Keeping in mind the background of the current scenario in 2022, outbreaks started in men who have sex with men (MSM) groups in London and involved a person from Nigeria. A Gay Pride Party in the Canaries served as the next base from which it spread throughout Europe and the US. As the number of reported cases in various countries rises, the worldwide medical community is concerned, and careful planning to coincide with a potential monkeypox outbreak is critical. To ensure that the condition is managed appropriately, fresh disease data must be collected as soon as feasible. Growing evidence suggests that groups with specific sexual risk behaviors are where monkeypox is most likely to spread. This community is also at a high risk for coinfection with HIV, HCV, or HBV, thus it is of particular relevance.